Click image to view full size image
Mazdutide is a glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) dual receptor agonist. It can simultaneously stimulate GLP-1R and GCGR, thereby exerting multiple metabolic regulatory effects.
1.Mazdutide is used to treat obesity and type 2 diabetes.
2.In multiple clinical studies, Mazdutide has shown significant weight loss. For example, in the GLORY-1 trial, patients treated Mazdutide had a significant weight loss in a dose-dependent manner.
3.Mazdutide is also able to improve cardiometabolic risks, such as reducing liver fat content and improving blood lipid levels.
|
Product Name |
CAS NO |
|
Semaglutide |
910463-68-2 |
|
Retatrutide |
2381089-83-2 |
|
Tirzepatide |
2023788-19-2 |
|
Cagrilintide |
1415456-99-3 |
|
Orforglipron |
2212020-52-3 |
|
Dulaglutide |
923950-08-7 |
|
Glucagon-like peptide -1;GLP-1 |
87805-34-3 |
|
Liraglutide |
204656-20-2 |
|
Mazdutide |
2259884-03-0 |
Sinov has its own factory, with many years of production and R&D experience in the pharmaceutical raw materials and pharmaceutical intermediates industry, weight loss peptide series is one of the hottest series for export in 2024, we also support OEM and ODM services while supplying raw materials for our products.
1.Send the purchasing products, specifications, quantity, address and other information to us by e-mail
2.The product manager will contact you at the first time.
3.After all negotiations, sign the purchase contract.
4.Delivery after payment for stock, and start production after payment for large special products.
http://www.sinovhealth.com/